Tag: Johnson & Johnson
Browse our exclusive articles!
Johnson & Johnson’s Q3 Earnings: Revenue And EPS Beat On Strong Cancer Drug Sales, Revises Annual Outlook To Reflect V-Wave Acquisition
On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales...
J&J lifts profit and sales forecasts, beats Wall Street expectations
By Patrick Wingrove and Bhanvi Satija(Reuters) - Johnson & Johnson raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of...
J&J lifts profit and sales forecasts, beats Wall Street expectations
Johnson & Johnson (JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly results that...
What To Expect in the Markets This Week
Coming up: Financial, tech and health-care earnings, Fed officials speaking, retail sales data, housing starts, bond market holiday MondayKey TakeawaysGoldman Sachs, Morgan Stanley, Citigroup,...
2 Unstoppable Dividend Stocks to Buy If There’s a Stock Market Sell-Off
The stock market is going strong, with the S&P 500 index heading for a 19% gain so far in 2024, confirming its presence in...